Transcept Pharmaceuticals Second-Quarter Net Loss Decreases to $2.06 Million

Transcept Pharmaceuticals second-quarter net loss decreases to .06 million
Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced financial results for the three and six months ended June 30, 2010.
Read more on News-Medical-Net

Grand Withdrawal Seizure
On Thursday morning, August 5, at approximately 9:30 a.m., a woman’s cries were heard in the Mission Center Road parking lot of the Ralphs grocery store.
Read more on San Diego Reader